The Brazilian Health Regulatory Agency has approved the commercial manufacture of VITAL, a breathing device designed specifically to address the needs of coronavirus patients.

PASADENA, Calif. (NASA PR) — In late April, NASA announced the development of Ventilator Intervention Technology Accessible Locally (VITAL), a ventilator prototype designed specifically to address the COVID-19 pandemic. Since then, 28 manufacturers around the world have been licensed to make the device. Now one of those licensees is preparing to begin production in Brazil.

PASADENA, Calif. (NASA PR) — After receiving more than 100 applications, NASA’s Jet Propulsion Laboratory (JPL) in Southern California has selected eight U.S. manufacturers to make a new ventilator tailored for coronavirus (COVID-19) patients.

The prototype, which was created by JPL engineers in just 37 days, received an Emergency Use Authorization  from the Food and Drug Administration on April 30.

PASADENA, Calif. (NASA PR) — A new high-pressure ventilator developed by NASA engineers and tailored to treat coronavirus (COVID-19) patients today was approved by the Food and Drug Administration (FDA) for use under the FDA’s March 24 ventilator Emergency Use Authorization.

Called VITAL (Ventilator Intervention Technology Accessible Locally), the device was developed by engineers at NASA’s Jet Propulsion Laboratory (JPL) in Southern California to free up the nation’s limited supply of traditional ventilators so they may be used on patients with the most severe COVID-19 symptoms.

WASHINGTON (NASA PR) — NASA has joined the fight against coronavirus (COVID-19) with efforts underway across the country to augment the national response, a few of which were highlighted in a media briefing today.

NEW YORK (NASA PR) — A new high-pressure ventilator developed by NASA engineers and tailored to treat coronavirus (COVID-19) patients passed a critical test Tuesday at the Icahn School of Medicine at Mount Sinai in New York, an epicenter of COVID-19 in the United States.

The device, called VITAL (Ventilator Intervention Technology Accessible Locally), was developed by engineers at NASA’s Jet Propulsion Laboratory in Southern California to free up the nation’s limited supply of traditional ventilators so they may be used on patients with the most severe COVID-19 symptoms.